• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Aegerion Pharmaceuticals Inc

+ Add to Watchlist

AEGR:US

30.0000 USD 0.9100 3.13%

As of 20:10:00 ET on 07/25/2014.

Snapshot for Aegerion Pharmaceuticals Inc (AEGR)

Open: 28.9700 Day's Range: 28.7500 - 30.1200 Volume: 827,192
Previous Close: 29.0900 52wk Range: 26.2500 - 101.0000 1-Yr Rtn: -61.79%

Stock Chart for AEGR

No chart data available.
  • AEGR:US 30.0000
  • 1D
  • 1M
  • 1Y
29.0900
Interactive AEGR Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for AEGR

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -2.1027
Est. EPS (USD) (12/2014) -0.9360
Est. PEG Ratio -
Market Cap (M USD) 884.49
Shares Outstanding (M) 29.48
30 Day Average Volume 758,762
Price/Book (mrq) 8.2208
Price/Sale (ttm) 11.8091
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 07/29/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for AEGR

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for AEGR

Aegerion Pharmaceuticals, Inc. is a biopharmaceutical company. The Company researches small-molecule therapeutics for cardiovascular and metabolic disease. Aegerion's product candidates limit secretion of cholesterol and triglycerides.

Marc D BeerChief Executive OfficerMark J FitzpatrickChief Financial Officer
Mark SumerayChief Medical OfficerMartha J CarterSenior VP/Chief Regulatory
More Company Profile & Key Executives for AEGR

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil